FDA Alerts
Bee Pollen Product Could Pose Health Risks
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Prime Bee Pollen, a product promoted and sold for weight loss on www.beeextremelyamazed.com and on www.beefitamy.com .
Sibutramine, Phenolphthalein Found in Weight Loss Product
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Evolve Bee Pollen, a product promoted and sold for weight loss on www.beeextremelyamazed.com and on www.beefitamy.com .
Fecal Continence Restoration System Approved
The U.S. Food and Drug Administration today approved the Fenix Continence Restoration System to treat fecal incontinence in patients who are not candidates for, or have previously failed, medical or other surgical options.
FDA Proposes Tanning Bed Ban for Underage Kids
Today, the U.S. Food and Drug Administration announced important proposed steps to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults.
Thirty Plus Supplement May Pose Health Risk
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Thirty Plus, a product promoted and sold for weight loss on various websites, including www.getskinny.bigcartel.com , and in some retail stores.
FDA: Do Not Take Power Tiger-X
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Power Tiger-X, a product promoted and sold for sexual enhancement on various websites, including www.everestwholesales.com , and in some retail stores.
Rx to Reverse Neuromuscular Blocking Approved
The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.
Chemo Overdose Rx Approved
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
Rare Enzyme Disorder Rx Approved
Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.
Weight Loss Supplement May Contain Hidden Drug
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Lipo Escultura, a product promoted and sold for weight loss on www.lipoesculturatreatment.com by JAT Productos Naturales Corp., but may also be distributed under the following aliases: Lipo Escultura Corporation and JAT Natural Products Corp.